This is a revised (A2) continuation application to extend an Institutional Postdoctoral Training Program in Drug Abuse Treatment and Services Research. Areas of focus are: (1) clinical trials of behavioral, psychosocial and pharmacological interventions, including the """"""""Stage I"""""""" developmental work that leads to clinical trials;(2) studies of processes that contribute to outcome;(3) efficacy and effectiveness of interventions in practice settings;and (4) intervention dissemination and diffusion. Trainees will be admitted for two years with the possibility of a third year. The exceptional trainee will be admitted for a one-year training program. In the past 15 years, the program has successfully trained 43 doctoral level nurses, psychologists, social workers, and public health and policy scientists for academic and research careers. Recent changes in policy and public perception of drug abuse serve to increase the already pressing need for outstanding researchers in treatment and services research. The program exists in an environment rich with relevant resources, including links with multiple, diverse clinical sites, and a variety of academic centers and activities that supplement and enrich the training experience. A seven-member Executive Committee, Drs. Hall, Sorensen, Batki,, Delucchi, Guydish, Masson, and Weisner, directs the program. Core Faculty includes biostatisticians, internists, psychiatrists, and psychologists. We will have a total of 6 trainees each year, in their first or second year of placement, or possibly their third year. All trainees participate in the Drug Abuse Research Seminar and Transmethodological Lecture Series and a course on the Responsible Conduct of Science, and one other course each semester selected from the wide array offered. Trainees'research projects are closely tied to those of their preceptors. As trainees move from year 1 to year 2, they progress from a project designed by their preceptor to an independently conceived project, which the trainee leads. Trainees are expected to make multiple scientific presentations, submit articles for publication, and prepare as well as revise grant submissions while in the problem.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Aklin, Will
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Francisco
Schools of Medicine
San Francisco
United States
Zip Code
Storholm, Erik D; Volk, Jonathan E; Marcus, Julia L et al. (2017) Risk Perception, Sexual Behaviors, and PrEP Adherence Among Substance-Using Men Who Have Sex with Men: a Qualitative Study. Prev Sci 18:737-747
Chang, Jamie Suki; Kushel, Margot; Miaskowski, Christine et al. (2017) Provider Experiences With the Identification, Management, and Treatment of Co-occurring Chronic Noncancer Pain and Substance Use in the Safety Net. Subst Use Misuse 52:251-255
Ray, G Thomas; Bahorik, Amber L; VanVeldhuisen, Paul C et al. (2017) Prescription opioid registry protocol in an integrated health system. Am J Manag Care 23:e146-e155
Campbell, Cynthia I; Bahorik, Amber L; Kline-Simon, Andrea H et al. (2017) The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study. Drug Alcohol Depend 178:170-175
Pagano, Anna; Gubner, Noah; Tajima, Barbara et al. (2017) Addiction Treatment Clients' Reactions to Graphic Warning Labels on Cigarette Packs. J Drug Issues 47:433-447
Bahorik, Amber L; Leibowitz, Amy; Sterling, Stacy A et al. (2017) Patterns of marijuana use among psychiatry patients with depression and its impact on recovery. J Affect Disord 213:168-171
Hurstak, Emily E; Kushel, Margot; Chang, Jamie et al. (2017) The risks of opioid treatment: Perspectives of primary care practitioners and patients from safety-net clinics. Subst Abus 38:213-221
Gubner, Noah R; Guydish, Joseph; Humfleet, Gary L et al. (2017) Nicotine biomarkers and rate of nicotine metabolism among cigarette smokers taking buprenorphine for opioid dependency. Drug Alcohol Depend 178:267-270
Bahorik, Amber L; Greeno, Catherine G; Cochran, Gerald et al. (2017) Motivation deficits and use of alcohol and illicit drugs among individuals with schizophrenia. Psychiatry Res 253:391-397
Bahorik, Amber L; Satre, Derek D; Kline-Simon, Andrea H et al. (2017) Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System. J Addict Med 11:3-9

Showing the most recent 10 out of 141 publications